US promises $2.1 billion for Sanofi, GSK coronavirus vaccine

Agence France Presse 07/31/2020

Pharma giants Sanofi and GSK are to receive up to $2.1 billion from the US government for the development of a COVID-19 vaccine, the companies said Friday, as the world continues to be ravaged by the coronavirus…

Confirmed: US voids Senator Bato dela Rosa’s visa

Maila Ager - INQUIRER.net 01/23/2020

MANILA, Philippines — Senator Ronald “Bato” Dela Rosa confirmed Wednesday that his US visa had been canceled. Dela Rosa, in separate text messages to reporters, disclosed that his US visa had been canceled and was told to…

US visa canceled? Dela Rosa would rather go to China

Marlon Ramos - Philippine Daily Inquirer 12/17/2019

  MANILA, Philippines — If Uncle Sam won’t allow him to see the Statue of Liberty, there’s always the Great Wall of China. Sen. Ronald “Bato” dela Rosa on Monday admitted that he’s disheartened by “rumors” that…

US turns over feasibility study on water supply project to Tacloban

PR 06/10/2015

AS part of the US government’s continuing commitment to help the people of Leyte recover from the destruction caused by typhoon Yolanda, the United States Embassy Manila turned over to Tacloban City the Rapid Feasibility Study for…

China suspected in massive breach of federal personnel data

06/05/2015

WASHINGTON – China-based hackers are suspected of breaking into the computer networks of the U.S. government personnel office and stealing identifying information of at least 4 million federal workers, American officials said. The Department of Homeland Security…

Major aid effort to help typhoon victims

11/10/2013

THE US and other governments and international agencies are mounting a major relief effort to help victims of supertyphoon Yolanda. Brian Goldbeck, the acting ambassador at the US Embassy in Manila, issued a disaster declaration to provide…

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.